Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 6
2015 4
2016 3
2017 5
2018 7
2019 2
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Emerging immunotherapies for glioblastoma.
Desai R, Suryadevara CM, Batich KA, Farber SH, Sanchez-Perez L, Sampson JH. Desai R, et al. Among authors: suryadevara cm. Expert Opin Emerg Drugs. 2016 Jun;21(2):133-45. doi: 10.1080/14728214.2016.1186643. Expert Opin Emerg Drugs. 2016. PMID: 27223671 Free PMC article. Review.
The Safety of available immunotherapy for the treatment of glioblastoma.
Farber SH, Elsamadicy AA, Atik AF, Suryadevara CM, Chongsathidkiet P, Fecci PE, Sampson JH. Farber SH, et al. Among authors: suryadevara cm. Expert Opin Drug Saf. 2017 Mar;16(3):277-287. doi: 10.1080/14740338.2017.1273898. Epub 2017 Jan 3. Expert Opin Drug Saf. 2017. PMID: 27989218 Free PMC article. Review.
Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors.
Boccalatte F, Mina R, Aroldi A, Leone S, Suryadevara CM, Placantonakis DG, Bruno B. Boccalatte F, et al. Among authors: suryadevara cm. Cancers (Basel). 2022 Oct 18;14(20):5108. doi: 10.3390/cancers14205108. Cancers (Basel). 2022. PMID: 36291891 Free PMC article. Review.
Epidermal growth factor receptor and variant III targeted immunotherapy.
Congdon KL, Gedeon PC, Suryadevara CM, Caruso HG, Cooper LJ, Heimberger AB, Sampson JH. Congdon KL, et al. Among authors: suryadevara cm. Neuro Oncol. 2014 Oct;16 Suppl 8(Suppl 8):viii20-5. doi: 10.1093/neuonc/nou236. Neuro Oncol. 2014. PMID: 25342601 Free PMC article. Review.
Are BiTEs the "missing link" in cancer therapy?
Suryadevara CM, Gedeon PC, Sanchez-Perez L, Verla T, Alvarez-Breckenridge C, Choi BD, Fecci PE, Sampson JH. Suryadevara CM, et al. Oncoimmunology. 2015 Apr 30;4(6):e1008339. doi: 10.1080/2162402X.2015.1008339. eCollection 2015 Jun. Oncoimmunology. 2015. PMID: 26155413 Free PMC article. Review.
Immunotherapy for malignant glioma.
Suryadevara CM, Verla T, Sanchez-Perez L, Reap EA, Choi BD, Fecci PE, Sampson JH. Suryadevara CM, et al. Surg Neurol Int. 2015 Feb 13;6(Suppl 1):S68-77. doi: 10.4103/2152-7806.151341. eCollection 2015. Surg Neurol Int. 2015. PMID: 25722935 Free PMC article.
Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase-mutant Glioma.
Spino M, Kurz SC, Chiriboga L, Serrano J, Zeck B, Sen N, Patel S, Shen G, Vasudevaraja V, Tsirigos A, Suryadevara CM, Frenster JD, Tateishi K, Wakimoto H, Jain R, Riina HA, Nicolaides TP, Sulman EP, Cahill DP, Golfinos JG, Isse K, Saunders LR, Zagzag D, Placantonakis DG, Snuderl M, Chi AS. Spino M, et al. Among authors: suryadevara cm. Clin Cancer Res. 2019 Feb 15;25(4):1261-1271. doi: 10.1158/1078-0432.CCR-18-2312. Epub 2018 Nov 5. Clin Cancer Res. 2019. PMID: 30397180 Free PMC article.
26 results